RECAM-J 2023: Validation and development of the Japanese version of RECAM for the diagnosis of DILI

Authors

Institutions

Publication Details

Journal
Kanzo
Published
2024-10-01
DOI
https://doi.org/10.2957/kanzo.65.482
Citations
1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RECAM-J 2023: Validation and development of the Japanese version of RECAM for the diagnosis of DILI

Atsushi Tanaka
1 citations
Kanzo
Atrial Fibrillation Management and Outcomes
0.40
article

RECAM-J 2023: Validation and development of the Japanese version of RECAM for the diagnosis of DILI

Atsushi Tanaka
article en
1 citations

Abstract

No abstract available for this paper.
KanzoVol. 65(10)
Teikyo University (JP)
Openalex Percentile: Top 32%
Atrial Fibrillation Management and Outcomes
0.40
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

RECAM-J 2023: Validation and development of the Japanese version of RECAM for the diagnosis of DILI — Atsushi Tanaka · Kanzo (2024) | TGRS Research Map | TGRS